Atlas Trials

A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies

Clinical trial NCT00772876 · COMPLETED

Trial details

NCT number
NCT00772876
Sponsor
Piramal Enterprises Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2008-12-01
Primary completion
2012-04-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.